Literature DB >> 19807666

The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.

Donna M Huryn1, Amos B Smith.   

Abstract

During the pilot phase of the NIH Molecular Library Screening Network, the Penn Center for Molecular Discovery focused on a series of projects aimed at high throughput screening and the development of probes of a variety of protease targets. This review provides our medicinal chemistry experience with two such targets--cathepsin B and cathepsin L. We describe our approach for hit validation, characterization and triage that led to a critical understanding of the nature of hits from the cathepsin B project. In addition, we detail our experience at hit identification and optimization that led to the development of a novel thiocarbazate probe of cathepsin L.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807666      PMCID: PMC2909000          DOI: 10.2174/156802609789753653

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  34 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.

Authors:  H Tsuge; T Nishimura; Y Tada; T Asao; D Turk; V Turk; N Katunuma
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

3.  Inhibitory effect of cathepsin B inhibitor CA 074 on mouse anti-rat mixed lymphocyte reaction: novel immunosuppressive strategy for indirect xenoantigen recognition.

Authors:  T Tohyama; H Kiyochi; K Narumoto; K Honda; N Kobayashi; M Kanoh; T Saibara; N Katunuma
Journal:  Transplant Proc       Date:  2000-08       Impact factor: 1.066

4.  Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.

Authors:  Kerim Babaoglu; Anton Simeonov; John J Irwin; Michael E Nelson; Brian Feng; Craig J Thomas; Laura Cancian; M Paola Costi; David A Maltby; Ajit Jadhav; James Inglese; Christopher P Austin; Brian K Shoichet
Journal:  J Med Chem       Date:  2008-03-12       Impact factor: 7.446

5.  Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.

Authors:  Parag P Shah; Michael C Myers; Mary Pat Beavers; Jeremy E Purvis; Huiyan Jing; Heather J Grieser; Elizabeth R Sharlow; Andrew D Napper; Donna M Huryn; Barry S Cooperman; Amos B Smith; Scott L Diamond
Journal:  Mol Pharmacol       Date:  2008-04-10       Impact factor: 4.436

6.  Molecular docking of cathepsin L inhibitors in the binding site of papain.

Authors:  Mary Pat Beavers; Michael C Myers; Parag P Shah; Jeremy E Purvis; Scott L Diamond; Barry S Cooperman; Donna M Huryn; Amos B Smith
Journal:  J Chem Inf Model       Date:  2008-07-04       Impact factor: 4.956

7.  Fluorescence spectroscopic profiling of compound libraries.

Authors:  Anton Simeonov; Ajit Jadhav; Craig J Thomas; Yuhong Wang; Ruili Huang; Noel T Southall; Paul Shinn; Jeremy Smith; Christopher P Austin; Douglas S Auld; James Inglese
Journal:  J Med Chem       Date:  2008-03-26       Impact factor: 7.446

8.  Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications.

Authors:  M E Guicciardi; H Miyoshi; S F Bronk; G J Gores
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

9.  Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents.

Authors:  Paul A Johnston; Karina M Soares; Sunita N Shinde; Caleb A Foster; Tong Ying Shun; Harold K Takyi; Peter Wipf; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2008-08       Impact factor: 1.738

10.  Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases.

Authors:  Nuzhat Motlekar; Scott L Diamond; Andrew D Napper
Journal:  Assay Drug Dev Technol       Date:  2008-06       Impact factor: 1.738

View more
  4 in total

1.  Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.

Authors:  Jayme L Dahlin; J Willem M Nissink; Subhashree Francis; Jessica M Strasser; Kristen John; Zhiguo Zhang; Michael A Walters
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

2.  Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition.

Authors:  Cristian Celis-Barros; Leslie Saavedra-Rivas; J Cristian Salgado; Bruce K Cassels; Gerald Zapata-Torres
Journal:  J Comput Aided Mol Des       Date:  2014-10-22       Impact factor: 3.686

3.  Droplet electrospray ionization mass spectrometry for high throughput screening for enzyme inhibitors.

Authors:  Shuwen Sun; Robert T Kennedy
Journal:  Anal Chem       Date:  2014-08-26       Impact factor: 6.986

Review 4.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.